Jin Medical International Ltd. (ZJYL) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ZJYL Revenue Growth
ZJYL Revenue Analysis (2018–2024)
As of May 8, 2026, Jin Medical International Ltd. (ZJYL) generated trailing twelve-month (TTM) revenue of $43.0 million, reflecting moderate decline in growth of -6.4% year-over-year. The most recent quarter (Q2 2025) recorded $9.9 million in revenue, down 23.7% sequentially.
Looking at the longer-term picture, ZJYL's 5-year compound annual growth rate (CAGR) stands at +2.9%, indicating moderate growth over time. The company achieved its highest annual revenue of $23.5 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including MPWR (+26.4% YoY), NVCR (+8.5% YoY), and LFUS (+12.6% YoY), ZJYL has underperformed the peer group in terms of revenue growth. Compare ZJYL vs MPWR →
ZJYL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ZJYLCurrent | $43M | -6.4% | +2.9% | 15.5% | |
 MPWR | $2.8B | +26.4% | +27.0% | 26.1% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 LFUS | $2.4B | +12.6% | +10.5% | 1.6% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
ZJYL Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $23.5M | +18.6% | $9.5M | 40.4% | $3.6M | 15.5% |
| 2023 | $19.8M | +3.3% | $6.8M | 34.2% | $2.9M | 14.5% |
| 2022 | $19.2M | -7.6% | $6.2M | 32.3% | $2.1M | 11.1% |
| 2021 | $20.8M | +28.2% | $6.4M | 30.6% | $2.6M | 12.7% |
| 2020 | $16.2M | -20.5% | $5.5M | 34.0% | $2.4M | 14.5% |
| 2019 | $20.4M | -2.6% | $7.5M | 36.9% | $4.4M | 21.6% |
| 2018 | $20.9M | - | $7.7M | 36.6% | $4.2M | 20.2% |
See ZJYL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZJYL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZJYL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
Is ZJYL's revenue growth accelerating or slowing?
ZJYL revenue declined -6.4% year-over-year, contrasting with the 5-year CAGR of +2.9%. TTM revenue fell to $43M. This reverses the prior growth trend.
What is ZJYL's long-term revenue growth rate?
Jin Medical International Ltd.'s 5-year revenue CAGR of +2.9% reflects the variable expansion pattern. Current YoY growth of -6.4% is below this long-term average.
How is ZJYL's revenue distributed by segment?
ZJYL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.